Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: A quantitative review

Annals of Allergy, Asthma and Immunology

Volumn 100, Issue 1, 2008, Pages 23-30

  Wlodarczyk, John H ^a   Gibson, Peter G ^b   Caeser, Manfred ^c  

^a John Wlodarczyk Consulting Services   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c ALTANA PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; MOMETASONE FUROATE; TRIAMCINOLONE ACETONIDE;

ARTICLE; ASTHMA; CLINICAL TRIAL; COCHRANE LIBRARY; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG MEGADOSE; EMBASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LOW DRUG DOSE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 37849031537     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60400-0     Document Type: Article

References (50)

1. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax. 2003;58(suppl 1):i1-i94.
2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Heart, Lung, and Blood Institute; 2002. NIH publication 02-3659.
3. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; July 1997. NIH publication 97-4051.
4. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 2002. NIH publication 02-5075.
5. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159: 941-955.
6. Macdessi JS, Randell TL, Donaghue KC, Ambler GR, van Asperen PP, Mellis CM. Adrenal crises in children treated with high-dose inhaled corticosteroids for asthma. Med J Aust. 2003;178:214-216.
7. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87:457-461.
8. Greenfield JR, Samaras K. Suppression of HPA axis in adults taking inhaled corticosteroids. Thorax. 2006;61:272-273.
9. Barnes NC, Hallett C, Harris TA. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med. 1998;92:95-104.
10. Bisgaard H, Damkjaer Nielsen M, Andersen B, et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol. 1988;81:1088-1095.
11. Clark DJ, Grove A, Cargill RI, Lipworth BJ. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax. 1996;51:262-266.
12. Kamada AK, Szefler SJ, Martin RJ, et al. Issues in the use of inhaled glucocorticoids: the Asthma Clinical Research Network. Am J Respir Crit Care Med. 1996;153:1739-1748.
13. McCubbin MM, Milavetz G, Grandgeorge S, et al. A bioassay for topical and systemic effect of three inhaled corticosteroids. Clin Pharmacol Ther. 1995;57:455-460.
14. Pedersen S, Fuglsang G. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J. 1988;1:433-435.
15. Prahl P, Jensen T. Decreased adreno-cortical suppression utilizing the Nebuhaler for inhalation of steroid aerosols. Clin Allergy. 1987;17: 393-398.
16. Prahl P. Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exp Allergy. 1991;21:145-146.
17. Dluhy RG. Clinical relevance of inhaled corticosteroids and HPA axis suppression. J Allergy Clin Immunol. 1998;101:S447-S450.
18. Chrousos GP, Harris AG. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy, 2: review of the literature. Neuroimmunomodulation. 1998;5:288-308.
19. Aaronson D, Kaiser H, Dockhorn R, et al. Effects of budesonide by means of the Turbuhaler on the hypothalamic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. J Allergy Clin Immunol. 1998;101:312-319.
20. Altman LC, Findlay SR, Lopez M, et al. Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 micrograms triamcinolone acetonide: multicenter study. Chest. 1992; 101:1250-1256.
21. Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, van Herwaarden CL. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma. Thorax. 1995;50:1044-1050.
22. Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol. 2001;87:379-385.
23. Clark DJ, Lipworth BJ. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax. 1997;52:55-58.
24. Clark DJ, Lipworth BJ. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Chest. 1997;112:1248-1252.
25. Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma. Am J Respir Crit Care Med. 1999;160:157-161.
26. Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J Respir Crit Care Med. 2004;170:960-966.
27. Hauache OM, Amarante EC, Vieira JG, et al. Evaluation of bone metabolism after the use of an inhaled glucocorticoid (flunisolide) in patients with moderate asthma. Clin Endocrinol. 1999;51:35-39.
28. Kannisto S, Laatikainen A, Taivainen A, Savolainen K, Tukiainen H, Voutilainen R. Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. Eur J Endocrinol. 2004;150:687-690.
29. Lawrence M, Wolfe J, Webb DR, et al. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity. Am J Respir Crit Care Med. 1997;156:744-751.
30. Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary- adrenal axis in asthmatic patients with severely impaired lung function. Ann Allergy Asthma Immunol. 2004;93:253-258.
31. Li JT, Ford LB, Chervinsky P, et al. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol. 1999;103:1062-1068.
32. Li JT, Goldstein MF, Gross GN, et al. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary- adrenal axis. J Allergy Clin Immunol. 1999;103:622-629.
33. 2-receptor function in the airways and adrenal responsiveness in bronchial asthma. Eur J Clin Pharmacol. 1988;34:577-583.
34. Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary- adrenal axis in adult patients with asthma. Clin Ther. 1999;21:353-367.
35. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109:410-418.
36. Weiner P, Berar-Yanay N, Davidovich A, Magadle R. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate. Chest. 1999;116:931-934.
37. Wilson AM, McFarlane LC, Lipworth BJ. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics. Am J Respir Crit Care Med. 1997;156:1274-1277.
38. Wilson AM, Lipworth BJ. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med. 2000;108:269-275.
39. Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ. Adrenocortical activity with repeated administration of once-daily inhaled fluticasone propionate and budesonide in asthmatic adults. Eur J Clin Pharmacol. 1998;53:317-320.
40. Wilson AM, Sims EJ, Struthers AD, Lipworth BJ. Inhaled corticosteroid therapy reduces the early morning peak in cortisol and aldosterone. Clin Sci. 1998;95:513-517.
41. Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med. 2002;165:1377-1383.
42. Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. Chest. 2000;118:1538-1546.
43. Currie GP, Fowler AM, Wilson EJ, Sims L, Orr C, Lipworth BJ. Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma. Thorax. 2002;57:865-868.
44. Wilson AM, Brewster HJ, Lipworth BJ. Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults. J Allergy Clin Immunol. 1998;102:751-756.
45. Boner AL. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children. J Allergy Clin Immunol. 2001;108: S32-S39.
46. Brutsche MH, Brutsche IC, Munawar M, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet. 2000;356:556-561.
47. Harrison TW, Tattersfield AE. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax. 2003;58:258-260.
48. Kelly HW, Nelson HS. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol. 2003;112:469-478.
49. Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA. 1999; 282:671-676.
50. Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet. 2000;355:542-545.